C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1994
10/18/1994	US5356777 Diagnosis of genetic mutations
10/18/1994	US5356775 Primary structure for functional expression from complementary DNA of a mammalian ATP-sensitive potassium channel
10/18/1994	US5356637 Method for preparing an enzymatic hydrolysate
10/18/1994	US5356623 Bacillus thuringiensis cryET1 toxin gene and protein toxic to lepidopteran insects
10/18/1994	US5356622 Homogenizing and sonicating flea midgut, separating and recovering
10/18/1994	US5356614 Process of preparing microparticulate collagen collagen-based products produced thereby and method of applying same
10/18/1994	US5356467 Controlled release coatings derived from aqueous dispersions of zein
10/18/1994	US5356374 Process for treating blood with polyimide carriers
10/17/1994	EP0630264A4 Ligands for improving metal chelate formation kinetics.
10/17/1994	CA2121302A1 Amphotropic virus receptor
10/17/1994	CA2094169A1 Agents for the prevention and cure of huntington disease in humans: cdna, precursor polypeptide hormone and active hormone reconstructed from the antisense strand of the huntingtondisease gene, "huntingtin"
10/14/1994	WO1993020213A1 Nisins
10/14/1994	CA2133578A1 Nisins
10/13/1994	WO1994023068A1 Method for screening for receptor agonists
10/13/1994	WO1994023067A1 Tumor-associated antigens recognized by t cells and the uses of these antigens
10/13/1994	WO1994023058A1 Suppressor of hiv replication and transcription
10/13/1994	WO1994023049A2 The introduction and expression of large genomic sequences in transgenic animals
10/13/1994	WO1994023048A2 Gibbon ape leukemia virus-based retroviral vectors
10/13/1994	WO1994023047A1 Biological control agents containing mollusc toxins
10/13/1994	WO1994023046A1 Dna sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
10/13/1994	WO1994023045A1 Method of inhibiting the transcription of genes
10/13/1994	WO1994023043A2 Control of plant abscission and pod dehiscence
10/13/1994	WO1994023041A2 Method for selective inactivation of viral replication
10/13/1994	WO1994023040A1 Methods and dna expression systems for over-expression of proteins in host cells
10/13/1994	WO1994023037A1 Pharmaceuticals based on papillomaviruses
10/13/1994	WO1994023036A1 Materials and methods for the control of wireworms
10/13/1994	WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II
10/13/1994	WO1994023034A2 Variant insulin-like growth factor i receptor subunits and methods for use thereof
10/13/1994	WO1994023033A1 Human osteoclast-specific and -related genes
10/13/1994	WO1994023032A1 Therapeutic uses of keratinocyte growth factor
10/13/1994	WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
10/13/1994	WO1994023030A2 Methods and materials relating to the functional domains of dna binding proteins
10/13/1994	WO1994023029A1 A nucleotide sequence encoding a chromosomal protein, associated chromosomal proteins and their uses
10/13/1994	WO1994023025A1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
10/13/1994	WO1994023024A1 Dna encoding cobra c3, cvf1, and cvf2
10/13/1994	WO1994023019A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
10/13/1994	WO1994023016A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
10/13/1994	WO1994022918A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
10/13/1994	WO1994022917A1 Cross-reactive influenza a immunization
10/13/1994	WO1994022916A1 Biologically active polypeptide fusion dimers
10/13/1994	WO1994022915A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994	WO1994022914A1 Chimeric cytokine receptors in lymphocytes
10/13/1994	WO1994022913A1 Antigenic polypeptides of t. ovis and vaccines containing such polypeptides
10/13/1994	WO1994022912A1 Antigenic polypeptides of t. ovis and vaccines containing such polypeptides
10/13/1994	WO1994022911A2 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE
10/13/1994	WO1994022910A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
10/13/1994	WO1994022909A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
10/13/1994	WO1994022906A1 Inhibitors of endothelin converting enzyme
10/13/1994	WO1994022905A1 Purification of factor vii
10/13/1994	WO1994022903A1 Separation of proteins
10/13/1994	WO1994022901A1 Epidermal growth factor inhibitor
10/13/1994	WO1994022895A1 Isolated nucleic acid molecule coding for toxin associated with kawasaki syndrome and uses thereof
10/13/1994	WO1994022497A1 Chelating agents of the type xn1s1o1 for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
10/13/1994	WO1994022494A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
10/13/1994	WO1994022493A1 Chelators of type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
10/13/1994	WO1994022492A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
10/13/1994	WO1994022491A1 Bifunctional chelators and their use in radiopharmaceuticals
10/13/1994	WO1994022489A1 Hybrid genes for use in the production of th-independent cytotoxic t cells
10/13/1994	WO1994022487A1 Use of a col 1a1 mini-gene construct to inhibit collagen synthesis
10/13/1994	WO1994022477A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
10/13/1994	WO1994022475A1 Cloned leptospira outer membrane protein
10/13/1994	WO1994022474A1 Method for treating kawasaki syndrome via immune modulation
10/13/1994	WO1994022472A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
10/13/1994	WO1994022467A1 Analogs of peptide yy and uses thereof
10/13/1994	WO1994022466A1 Methods of using insulin-like growth factor binding proteins
10/13/1994	WO1994022465A1 Method for reducing the viscosity of pathological mucoid airway contents in the respiratoy tract
10/13/1994	WO1994022464A1 Urokinase plasminogen activator fragments
10/13/1994	WO1994022460A1 Diagnosis and treatment of erectile dysfunction
10/13/1994	WO1994020621A3 Proteinaceous particles containing retroviral element
10/13/1994	WO1994020620A3 Cloning of the zymocin gene and use of zymocin in beverages
10/13/1994	WO1994020530A3 Neuropeptides and their use as insecticides
10/13/1994	WO1994018332A3 Anthrax toxin fusion proteins and uses thereof
10/13/1994	WO1994018227A3 Improved method for the refolding of proteins
10/13/1994	WO1994017828A3 Treatment for insulin dependent diabetes
10/13/1994	WO1994016079A3 Novel bacillus thuringiensis toxins active against corn rootworm larvae
10/13/1994	WO1994012635A3 Novel seven transmembrane receptors
10/13/1994	WO1994012630A3 Method for producing polypeptide via bacterial fermentation
10/13/1994	DE4311756A1 Modified peptides, pharmaceutical compositions containing these compounds, and processes for their production
10/13/1994	CA2160154A1 Methods of using insulin-like growth factor binding proteins
10/13/1994	CA2160135A1 Method for screening for receptor agonists
10/13/1994	CA2160127A1 Dna encoding cobra c3, cvf1, and cvf2
10/13/1994	CA2160011A1 Chimeric cytokine receptors in lymphocytes
10/13/1994	CA2159898A1 Hybrid genes for use in the production of t h-independent cytotoxic t cells
10/13/1994	CA2159639A1 Method for selective inactivation of viral replication
10/13/1994	CA2159637A1 Urokinase plasminogen activator fragments
10/13/1994	CA2159595A1 Suppressor of hiv replication and transcription
10/13/1994	CA2159506A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994	CA2159499A1 Biologically active polypeptide fusion dimers
10/13/1994	CA2159471A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
10/13/1994	CA2159445A1 Radiolabeled platelet gpiib/iiia receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
10/13/1994	CA2159313A1 Purification of factor vii
10/13/1994	CA2159205A1 Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract
10/13/1994	CA2159195A1 Use of a col 1a1 mini-gene construct to inhibit collagen synthesis
10/13/1994	CA2159114A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
10/13/1994	CA2159080A1 Human osteoclast-specific and -related genes
10/13/1994	CA2159072A1 Novel processes and intermediate compounds for the preparation of platelet glycoprotein iib/iiia inhibitors
10/13/1994	CA2159070A1 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
10/13/1994	CA2159069A1 A process and intermediate compounds useful for the preparation of platelet glycoprotein iib/iiia inhibitors containing n -a- methylarginine
10/13/1994	CA2158554A1 Pharmaceuticals based on papillomaviruses
10/13/1994	CA2158540A1 Cloned leptospira outer membrane protein

1 ... 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 ... 2916